On-demand webinar thumbnail showing a hand touching a digital data screen

Implementing a Gold Standard FSP Strategic Partnership to Fuel Efficient Drug Development

1 minute read

Webinars

Published: March 7th, 2024

Complete the form below to watch the webinar

Featuring:

  • Francis Kendall, Head of Oncology Statistical Programming, Biometrics, Oncology R&D, AstraZeneca
  • Alan Salter, Director, R&D Clinical Partner Management, Takeda
  • Ping-Chung Chang, Head Business Transformation, Phastar
  • Elisa Mansfield, Vice President, FSP, Phastar

Moderated by Natalie Fforde, Senior Vice President, Global Strategic Partnerships, Phastar

Related articles

Smarter Confidence Intervals in Multicenter Trials: The BSVI Advantage
Webinars

Smarter Confidence Intervals in Multicenter Trials: The BSVI Advantage

October 12th, 2026 2 minute read

Confidence intervals are an important component of clinical trial reporting, supporting the accurate and reliable int...

Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA
Webinars

Regulatory Expectations: Bayesian Guidance from the FDA, CDE, and EMA

September 28th, 2026 2 minute read

Bayesian methods are increasingly being considered to support dose optimization, extrapolation, and adaptive designs ...

AI for Clinical Research Series – Prediction
Webinars

AI for Clinical Research Series – Prediction

June 26th, 2026 1 minute read

Augmenting Clinical Trials with Synthetic or Simulated Patients, Projecting Long-Term Benefit-Risk, and Developing Re...